Back to Search Start Over

The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients

Authors :
Ronsini, C.
Anchora, L. P.
Restaino, S.
Fedele, C.
Arciuolo, Damiano
Teodorico, Elena
Bizzarri, N.
Zannoni, Gian Franco
Ferrandina, Maria Gabriella
Scambia, Giovanni
Fanfani, Francesco
Arciuolo D.
Teodorico E.
Zannoni G. F. (ORCID:0000-0003-1809-129X)
Ferrandina G. (ORCID:0000-0003-4672-4197)
Scambia G. (ORCID:0000-0003-2758-1063)
Fanfani F. (ORCID:0000-0003-1991-7284)
Ronsini, C.
Anchora, L. P.
Restaino, S.
Fedele, C.
Arciuolo, Damiano
Teodorico, Elena
Bizzarri, N.
Zannoni, Gian Franco
Ferrandina, Maria Gabriella
Scambia, Giovanni
Fanfani, Francesco
Arciuolo D.
Teodorico E.
Zannoni G. F. (ORCID:0000-0003-1809-129X)
Ferrandina G. (ORCID:0000-0003-4672-4197)
Scambia G. (ORCID:0000-0003-2758-1063)
Fanfani F. (ORCID:0000-0003-1991-7284)
Publication Year :
2021

Abstract

Objective: Lymph vascular space involvement (LVSI) is one of the most important prognostic factors in early stage cervical cancer. Its qualitative evaluation represents a milestone for patient risk stratification and treatment choice, but a semi-quantitative analysis of LVSI may offer a more truthful risk model, as already demonstrated for endometrial cancer. The present study aims to investigate the performances of a semi-quantitative evaluation of LVSI in terms of patient risk assessment. Methods: In this retrospective study were enrolled patients underwent surgical treatment for early cervical cancer from January 2009 to October 2018. A semi-quantitative evaluation such as the “three-tiered approach” was used to classify the LVSI pathway: negative vs. focal vs. diffuse. Results: Diffuse LVSI was found to be a risk factor for lymph node metastasis (OR: 9.844, p < 0.001), and parametrial involvement (OR: 5.566, p < 0.001). Lymph nodal recurrences were more frequent in diffuse LVSI group (LVSI negative vs. focal LVSI p = 0.369; LVSI negative vs. diffuse LVSI p = 0.002; Focal LVSI vs. diffuse LVSI p = 0.214); and so distant recurrences (LVSI negative vs. focal LVSI p = 0.623; LVSI negative vs. diffuse LVSI p = 0.002; Focal LVSI vs. diffuse LVSI p = 0.026). Patients with diffuse LVSI showed a worse disease-free survival (DFS) than patients with focal or absent involvement (DFS LVSI negative vs. focal LVSI p = 0.938; LVSI negative vs. diffuse LVSI p < 0.001; focal LVSI vs. diffuse LVSI p = 0.036). Conclusion: Semi-quantitative evaluation of LVSI may be useful to identify risk patients for shorter disease-free survival and lymphatic and distant recurrences in patients with early stage.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1330708864
Document Type :
Electronic Resource